해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)

 

구분	보고서 (영문)
제약/바이오/ 임상시험	BMS's Breyanzi Sets New Standards as the First CAR T-Cell Therapy for CLL and SLL
	CRISPR-Based Assay Could Revolutionize Diagnosis of NTM Infections
	Pfizer’s Velsipity UK Approval Raises Competition in the Ulcerative Colitis Market
	Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023
	Europe Continues to Have the Most Pollen Allergy Clinical Trials
	Rare Disease Pipeline Analysis 2023
	Oncology Leads Trials for 2023 with More Than 52% of Trials in Phase II
	Nanoscope Therapeutics Exhibits Positive Top-Line Phase IIb Results for MCO-010
	Antibody-Drug Conjugates (ADC): Market Overview
	Rubraca Sheds Positive Light for PARP Inhibitors in Endometrial Cancer
	MASH Revival with Over $2.5 Billion for Innovator Drug Partnership Deals in 2024
	Lenmeldy Becomes the World’s Most Expensive Drug at a Wholesale Acquisition Cost of $4 million
	FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
	Surges in Obesity Drugs Forecast to Enter US Market
질환별	After Decades of Waiting, Late-Stage Therapies May Penetrate the COPD Market This Year
	Experts Flag Concerns with Drug Compliance in Osteoporosis Landscape
	Cell & Gene Therapies in Ophthalmology
	Fuchs Endothelial Corneal Dystrophy (FECD):Competitive Landscape
	Rheumatoid Arthritis: Competitive Landscape
	Peripheral Artery Disease: Competitive Landscape
	Retinitis Pigmentosa: Competitive Landscape
	Resistant hypertension: Competitive Landscape
컨퍼런스/ 심포지엄/ 학회/기타	World Tuberculosis Day 2024: New Vaccines Needed to Tackle Disease Burden
	Cheap Drugs, Inspections, and a Future War in Europe – What’s Really Driving Drug Shortages?
	CRISPR Drug Licensing Deals Secure $21 Billion in Top 3 Therapy Areas Over 5 Years
	The Wolbachia Method in the Battle Against Dengue